One group focused on the association of KRAS mutation to FDG-PET radiomics of pancreatic ductal adenocarcinoma patients [108], concluding that low-intensity textural features were significantly associated with KRAS gene mutational status (AUC = 0.794–0.82, training). This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.